Teladoc Secures $300M Credit Facility with JPMorgan

Teladoc Health has secured a $300 million credit facility with JPMorgan Chase Bank to enhance financial and operational flexibility. The five-year facility has no immediate borrowing plans and includes financial covenants to maintain leverage and interest coverage ratios. The most recent analyst rating on Teladoc stock is a Buy with a $14.00 price target.

Title: Teladoc Health Secures $300 Million Credit Facility with JPMorgan Chase Bank

Teladoc Health, Inc. has recently secured a $300 million credit facility with JPMorgan Chase Bank, N.A., to enhance its financial and operational flexibility. The five-year, senior secured revolving credit facility, which does not currently have any immediate borrowing plans, was announced in a recent Form 8-K filing with the U.S. Securities and Exchange Commission [2].

The credit facility, which matures on July 17, 2030, is subject to variable interest rates that range from 2.75% to 3.25% per annum, based on the company's secured net leverage ratio. Additionally, the facility includes financial covenants to maintain a maximum secured net leverage ratio of 3.50:1.00 and a minimum consolidated interest coverage ratio of 3.00:1.00 [2].

Teladoc Health's capital allocation priorities remain unchanged, focusing on maintaining a strong balance sheet, investing in the business, and evaluating share repurchases as a potential use of excess cash. The company's current analyst rating is a Buy with a $14.00 price target, reflecting positive sentiment among investors [1].

The recent credit agreement underscores Teladoc Health's commitment to preserving liquidity and financial flexibility, which is crucial for its strategic initiatives and growth plans. The facility is not subject to amortization and will mature on the fifth anniversary of the effective date.

References
[1] https://simplywall.st/stocks/us/banks/nyse-jpm/jpmorgan-chase/news/tech-mahindra-joins-jpmorgan-chase-jpm-to-enhance-global-pay
[2] https://www.sec.gov/Archives/edgar/data/1477449/000147744925000091/tdoc-20250717.htm